| Primary |
| Hypertension |
37.5% |
| Product Used For Unknown Indication |
25.0% |
| Essential Hypertension |
12.5% |
| Hypothyroidism |
12.5% |
| Renal Failure Chronic |
12.5% |
|
| Hypoglycaemia |
50.0% |
| Melaena |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
47.0% |
| Hypertension |
13.1% |
| Rheumatoid Arthritis |
7.1% |
| Product Used For Unknown Indication |
5.7% |
| Type 2 Diabetes Mellitus |
3.9% |
| Gait Disturbance |
3.2% |
| Cardiac Failure |
2.5% |
| Prophylaxis |
2.5% |
| Colorectal Cancer Metastatic |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Atrial Fibrillation |
1.4% |
| Colorectal Cancer |
1.4% |
| Osteoporosis |
1.4% |
| Parkinsonism |
1.4% |
| Diarrhoea |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Infection Prophylaxis |
1.1% |
| Ischaemic Cardiomyopathy |
1.1% |
| Muscle Spasticity |
1.1% |
| Contraception |
0.7% |
|
| Renal Failure Acute |
14.3% |
| Sepsis |
10.2% |
| Rhabdomyolysis |
8.2% |
| Bradycardia |
6.1% |
| Pancreatitis |
6.1% |
| Respiratory Arrest |
6.1% |
| Somnolence |
6.1% |
| Bladder Neoplasm |
4.1% |
| Diabetic Hyperosmolar Coma |
4.1% |
| Hypertension |
4.1% |
| Hypotension |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Malaise |
4.1% |
| Respiratory Acidosis |
4.1% |
| Weight Decreased |
4.1% |
| Diarrhoea |
2.0% |
| Foetal Growth Retardation |
2.0% |
| Haematuria |
2.0% |
| Hyperglycaemia |
2.0% |
| Hypoglycaemia Unawareness |
2.0% |
|
| Concomitant |
| Hypertension |
25.3% |
| Drug Use For Unknown Indication |
21.1% |
| Product Used For Unknown Indication |
9.8% |
| Rheumatoid Arthritis |
6.3% |
| Hepatitis C |
3.2% |
| Osteoporosis |
3.1% |
| Prophylaxis |
3.1% |
| Ill-defined Disorder |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Depression |
2.8% |
| Diabetes Mellitus |
2.7% |
| Atrial Fibrillation |
2.5% |
| Non-small Cell Lung Cancer |
2.3% |
| Hypercholesterolaemia |
2.0% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Essential Hypertension |
1.6% |
| Multiple Myeloma |
1.6% |
| Hyperlipidaemia |
1.5% |
| Acute Lymphocytic Leukaemia |
1.4% |
|
| Renal Failure |
10.0% |
| Thrombocytopenia |
9.2% |
| Hyponatraemia |
7.5% |
| Weight Decreased |
6.7% |
| Renal Impairment |
5.8% |
| Acute Pulmonary Oedema |
5.0% |
| Fall |
5.0% |
| Nephrogenic Systemic Fibrosis |
5.0% |
| Rectal Haemorrhage |
5.0% |
| Tremor |
5.0% |
| Renal Failure Acute |
4.2% |
| Thrombotic Microangiopathy |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Blood Pressure Increased |
3.3% |
| Leukocytoclastic Vasculitis |
3.3% |
| Lymphoproliferative Disorder |
3.3% |
| Malaise |
3.3% |
| Melaena |
3.3% |
| Rhabdomyolysis |
3.3% |
| Sudden Death |
3.3% |
|
| Interacting |
| Disseminated Tuberculosis |
35.7% |
| Hypertension |
35.7% |
| Hypertensive Cardiomyopathy |
21.4% |
| Drug Use For Unknown Indication |
7.1% |
|
| Drug Interaction |
33.3% |
| Hepatic Failure |
33.3% |
| Spinal Compression Fracture |
33.3% |
|
